Aqua Bio Technology ASA (ABTEC) NOK2.5

Sell:0.59 NOKBuy:0.64 NOK0.02 NOK (2.79%)

Prices delayed by at least 15 minutes
Sell:0.59 NOK
Buy:0.64 NOK
Change:0.02 NOK (2.79%)
Prices delayed by at least 15 minutes
Sell:0.59 NOK
Buy:0.64 NOK
Change:0.02 NOK (2.79%)
Prices delayed by at least 15 minutes

Company Information

About this company

Aqua Bio Technology ASA is a Norway-based skincare company. The Company develops and commercializes sustainable biotechnology for use in skin care products. ABT develops new active ingredients for skincare based on marine technology with documented positive effects on human skin. The ingredients are based on natural and sustainable substances, found in plants, algae and in the oceans and provide the cosmetics industry with natural alternatives to traditional ingredients. In addition to ingredients from its own technology, ABT also markets and distributes natural skincare products to consumers, retailers and professional users in Europe and the Middle East. The ABT portfolio of skincare products contains exclusive and high-end products as well as off the shelf products. They are distributed over the Internet, in stores and through professional channels such as skincare clinics.

Key people

Jon Olav Odegard
Chairman of the Board
Fredrik W. Henriksen
Chief Executive Officer
Geir Udnaes
Chief Financial Officer
Espen Kvale
Chief Operating Officer
Hans Kristian Leren
Chief Technical Officer
Arvid Lindberg
Head of Sales and Marketing
Kristin Aase
Director
Camilla Helena Andersson
Director
Tone Bjornov
Director
Roger Hofseth
Director
David Huggins
Director
Click to see more

Key facts

  • EPIC
    ABTEC
  • Location
    Norway
  • Sector
    Consumer/Non-Cyclical
  • Industry
    Personal & Household Prods.
  • ISIN
    NO0010307135
  • Market cap
    NOK 73.96m
  • Employees
    4
  • Shares in issue
    58.58m
  • Exchange
    Oslo Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.